How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Existing assessments of this procedure

    A clinical practice guideline on the non-invasive management of soft tissue disorders of the shoulder from the Ontario Protocol for Traffic Injury Management collaboration was published in 2021 (Yu et al. 2021). This was based on 7 systematic reviews examining the effectiveness and safety of non-invasive interventions for the management of soft tissue disorders of the shoulder. The recommendations state that shockwave therapy should not be offered for shoulder pain with duration more than 3 months, but clinicians may consider it for shoulder pain with calcific tendonitis.

    The Canadian Agency for Drugs and Technologies in Health published a bulletin on extracorporeal shock wave treatment for chronic rotator cuff tendonitis in 2007 (Ho 2007). This stated that the evidence 'supports the use of high-energy ESWT for chronic calcific rotator cuff tendonitis, but not for non-calcific rotator cuff tendonitis. High-quality RCTs with larger sample sizes are needed to provide stronger evidence.'